IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1801 
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


This article has been cited by
1A review of mammalian carcinogenicity study design and potential effects of alternate test procedures on the safety evaluation of food ingredients
A.W. Hayes,A.D. Dayan,W.C. Hall,R.L. Kodell,G.M. Williams,W.D. Waddell,R.S. Slesinski,C.L. Kruger
Regulatory Toxicology and Pharmacology.2011;60(1)S1
[DOI]
2A review of mammalian carcinogenicity study design and potential effects of alternate test procedures on the safety evaluation of food ingredients
V.P. Sangeetha,N.S. Remya,P.V. Mohanan
Regulatory Toxicology and Pharmacology.2022;60(1)309
[DOI]
3Novel na´ve Bayes classification models for predicting the carcinogenicity of chemicals
Hui Zhang,Zhi-Xing Cao,Meng Li,Yu-Zhi Li,Cheng Peng
Food and Chemical Toxicology.2016;97(1)141
[DOI]
4Novel na´ve Bayes classification models for predicting the carcinogenicity of chemicals
N.S. Remya,V.P. Sangeetha,P.V. Mohanan
Food and Chemical Toxicology.2022;97(1)483
[DOI]
5Reassessing the two-year rodent carcinogenicity bioassay: A review of the applicability to human risk and current perspectives
Palma Ann Marone,William C. Hall,A. Wallace Hayes
Regulatory Toxicology and Pharmacology.2014;68(1)108
[DOI]
6Reassessing the two-year rodent carcinogenicity bioassay: A review of the applicability to human risk and current perspectives
Palma Ann Marone,William C. Hall,A. Wallace Hayes
Regulatory Toxicology and Pharmacology.2010;68(1)70
[DOI]
7Studies in rodents with the dipeptidyl peptidase-4 inhibitor vildagliptin to evaluate possible drug-induced pancreatic histological changes that are predictive of pancreatitis and cancer development in man
S. J. Busch,P. Hoffmann,P. Sahota,R. Johnson,W. Kothny,F. Meyer,J. E. Foley
Diabetes, Obesity and Metabolism.2013;15(1)72
[DOI]
8Studies in rodents with the dipeptidyl peptidase-4 inhibitor vildagliptin to evaluate possible drug-induced pancreatic histological changes that are predictive of pancreatitis and cancer development in man
S. J. Busch,P. Hoffmann,P. Sahota,R. Johnson,W. Kothny,F. Meyer,J. E. Foley
Diabetes, Obesity and Metabolism.2011;15(1)477
[DOI]
9Studies in rodents with the dipeptidyl peptidase-4 inhibitor vildagliptin to evaluate possible drug-induced pancreatic histological changes that are predictive of pancreatitis and cancer development in man
Joy A. Cavagnaro
Diabetes, Obesity and Metabolism.2010;15(1)477
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow